On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer footing following an extended ...

The startup is developing “modified DNA” therapies it claims can combine the strengths of multiple approaches, from messenger ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Alabama A&M University students made a strong showing at a statewide biotechnology symposium, bringing home top honors at the ...

At the center of AV Laboratories’ innovation is its patented AVL SOM3® complex, a scientifically engineered formulation ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...

Vir Biotechnology, Inc. (NASDAQ:VIR) is one of the must-buy small cap stocks to buy. On April 13, Vir Biotechnology, Inc.

Do you want to be at the forefront of the rapidly growing biotechnology field? Do you want to develop products derived from living organisms and biomolecules? Do you have a passion for biochemistry, ...

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund ...

EU Biotech Act I simplifies trials, boosts biomanufacturing, and aims for €10B investment to strengthen Europe's health ...

The longevity biotechnology industry is rapidly evolving with the amount of academic funding and venture investment increasing at the exponential pace. Over thirty longevity startups and approximately ...

Biotechnology advances offer immense public health and consumer potential, but come with serious risks. A recent workshop held by the Council on Foreign Relations brought experts together to discuss ...